Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality.

Talmi-Frank D, Altboum Z, Solomonov I, Udi Y, Jaitin DA, Klepfish M, David E, Zhuravlev A, Keren-Shaul H, Winter DR, Gat-Viks I, Mandelboim M, Ziv T, Amit I, Sagi I.

Cell Host Microbe. 2016 Oct 12;20(4):458-470. doi: 10.1016/j.chom.2016.09.005.

2.

Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.

Glinert I, Bar-David E, Sittner A, Weiss S, Schlomovitz J, Ben-Shmuel A, Mechaly A, Altboum Z, Kobiler D, Levy H.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4878-85. doi: 10.1128/AAC.00546-16. Print 2016 Aug.

3.

Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.

Weiss S, Altboum Z, Glinert I, Schlomovitz J, Sittner A, Bar-David E, Kobiler D, Levy H.

Antimicrob Agents Chemother. 2015 Dec;59(12):7497-503. doi: 10.1128/AAC.01376-15. Epub 2015 Sep 21.

4.

The central nervous system as target of Bacillus anthracis toxin independent virulence in rabbits and guinea pigs.

Levy H, Glinert I, Weiss S, Bar-David E, Sittner A, Schlomovitz J, Altboum Z, Kobiler D.

PLoS One. 2014 Nov 6;9(11):e112319. doi: 10.1371/journal.pone.0112319. eCollection 2014.

5.

Digital cell quantification identifies global immune cell dynamics during influenza infection.

Altboum Z, Steuerman Y, David E, Barnett-Itzhaki Z, Valadarsky L, Keren-Shaul H, Meningher T, Mendelson E, Mandelboim M, Gat-Viks I, Amit I.

Mol Syst Biol. 2014 Feb 28;10:720. doi: 10.1002/msb.134947. Print 2014.

6.

Toxin-independent virulence of Bacillus anthracis in rabbits.

Levy H, Glinert I, Weiss S, Sittner A, Schlomovitz J, Altboum Z, Kobiler D.

PLoS One. 2014 Jan 8;9(1):e84947. doi: 10.1371/journal.pone.0084947. eCollection 2014.

7.

Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.

Levy H, Weiss S, Altboum Z, Schlomovitz J, Glinert I, Sittner A, Shafferman A, Kobiler D.

Infect Immun. 2012 Aug;80(8):2623-31. doi: 10.1128/IAI.00244-12. Epub 2012 May 14.

8.

The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.

Levy H, Weiss S, Altboum Z, Schlomovitz J, Rothschild N, Glinert I, Sittner A, Kobiler D.

Microb Pathog. 2012 Jan;52(1):55-60. doi: 10.1016/j.micpath.2011.10.002. Epub 2011 Oct 17.

PMID:
22020310
9.

Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits.

Levy H, Weiss S, Altboum Z, Schlomovitz J, Rothschild N, Blachinsky E, Kobiler D.

Microb Pathog. 2011 Nov;51(5):345-51. doi: 10.1016/j.micpath.2011.07.004. Epub 2011 Jul 20.

PMID:
21791242
10.

Antibiotics cure anthrax in animal models.

Weiss S, Kobiler D, Levy H, Pass A, Ophir Y, Rothschild N, Tal A, Schlomovitz J, Altboum Z.

Antimicrob Agents Chemother. 2011 Apr;55(4):1533-42. doi: 10.1128/AAC.01689-10. Epub 2011 Jan 24.

11.

Progress and novel strategies in vaccine development and treatment of anthrax.

Chitlaru T, Altboum Z, Reuveny S, Shafferman A.

Immunol Rev. 2011 Jan;239(1):221-36. doi: 10.1111/j.1600-065X.2010.00969.x. Review.

PMID:
21198675
12.

Involvement of TLR2 in innate response to Bacillus anthracis infection.

Weiss S, Levy H, Fisher M, Kobiler D, Altboum Z.

Innate Immun. 2009 Feb;15(1):43-51. doi: 10.1177/1753425908100379.

PMID:
19201824
13.

Protective antigen as a correlative marker for anthrax in animal models.

Kobiler D, Weiss S, Levy H, Fisher M, Mechaly A, Pass A, Altboum Z.

Infect Immun. 2006 Oct;74(10):5871-6.

14.

Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.

Gat O, Grosfeld H, Ariel N, Inbar I, Zaide G, Broder Y, Zvi A, Chitlaru T, Altboum Z, Stein D, Cohen S, Shafferman A.

Infect Immun. 2006 Jul;74(7):3987-4001.

15.
16.

The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant.

Gat O, Mendelson I, Chitlaru T, Ariel N, Altboum Z, Levy H, Weiss S, Grosfeld H, Cohen S, Shafferman A.

Mol Microbiol. 2005 Oct;58(2):533-51.

17.

Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.

Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.

Vaccine. 2005 Dec 1;23(48-49):5688-97. Epub 2005 Feb 5.

PMID:
16039760
18.

Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.

Aloni-Grinstein R, Gat O, Altboum Z, Velan B, Cohen S, Shafferman A.

Infect Immun. 2005 Jul;73(7):4043-53.

19.

Identification of strain specific markers in Bacillus anthracis by random amplification of polymorphic DNA.

Levy H, Fisher M, Ariel N, Altboum Z, Kobiler D.

FEMS Microbiol Lett. 2005 Mar 1;244(1):199-205.

21.
22.

Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs.

Altboum Z, Gozes Y, Barnea A, Pass A, White M, Kobiler D.

Infect Immun. 2002 Nov;70(11):6231-41.

23.

Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.

Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z.

Infect Immun. 2002 Feb;70(2):544-60.

24.

Detection of specific Bacillus anthracis spore biomarkers by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Elhanany E, Barak R, Fisher M, Kobiler D, Altboum Z.

Rapid Commun Mass Spectrom. 2001;15(22):2110-6.

PMID:
11746875
26.

Search for correlates of protective immunity conferred by anthrax vaccine.

Reuveny S, White MD, Adar YY, Kafri Y, Altboum Z, Gozes Y, Kobiler D, Shafferman A, Velan B.

Infect Immun. 2001 May;69(5):2888-93.

27.

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.

Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shafferman A.

Infect Immun. 2000 Aug;68(8):4549-58.

28.

Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization.

Roth-Ben Arie Z, Altboum Z, Berdicevsky I, Segal E.

Mycopathologia. 1998;141(3):127-35.

PMID:
9755504
29.

Adhesion of Candida albicans mutant strains to host tissue.

Arie ZR, Altboum Z, Sandovsky-Losica H, Segal E.

FEMS Microbiol Lett. 1998 Jun 15;163(2):121-7.

30.

Adhesion of Candida albicans to epithelial cells--effect of nikkomycin.

Segal E, Gottlieb S, Altboum Z, Gov Y, Berdicevsky I.

Mycoses. 1997 Jan-Feb;40(1-2):33-9.

PMID:
9260479
31.

Adhesion of Candida albicans to epithelial cells effect of polyoxin D.

Gottlieb S, Altboum Z, Savage DC, Segal E.

Mycopathologia. 1991 Sep;115(3):197-205.

PMID:
1749403
32.

Isolation of the Candida albicans histidinol dehydrogenase (HIS4) gene and characterization of a histidine auxotroph.

Altboum Z, Gottlieb S, Lebens GA, Polacheck I, Segal E.

J Bacteriol. 1990 Jul;172(7):3898-904.

33.

Supplemental Content

Loading ...
Support Center